Home  |  Contact

UniProtKB/Swiss-Prot P05107: Variant p.Ala239Thr

Integrin beta-2
Gene: ITGB2
Variant information

Variant position:  239
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Alanine (A) to Threonine (T) at position 239 (A239T, p.Ala239Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and hydrophobic (A) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]: LAD1 patients have recurrent bacterial infections and their leukocytes are deficient in a wide range of adhesion-dependent functions. {ECO:0000269|PubMed:1346613, ECO:0000269|PubMed:1347532, ECO:0000269|PubMed:1352501, ECO:0000269|PubMed:1590804, ECO:0000269|PubMed:1694220, ECO:0000269|PubMed:1968911, ECO:0000269|PubMed:20529581, ECO:0000269|PubMed:20549317, ECO:0000269|PubMed:7509236, ECO:0000269|PubMed:7686755, ECO:0000269|PubMed:9884339}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In LAD1.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  239
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  769
The length of the canonical sequence.

Location on the sequence:   TEVGKQLISGNLDAPEGGLD  A MMQVAACPEEIGWRNVTRLL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLL

Mouse                         TEVGKQLISGNLDAPEGGLDAIMQVAACPEEIGWRNVTRLL

Pig                           TEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLL

Bovine                        TEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLL

Goat                          TEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLL

Sheep                         TEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLL

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 23 – 769 Integrin beta-2
Topological domain 23 – 700 Extracellular
Domain 124 – 363 VWFA
Glycosylation 254 – 254 N-linked (GlcNAc...) asparagine
Disulfide bond 33 – 447
Helix 236 – 245


Literature citations

Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene.
Parvaneh N.; Mamishi S.; Rezaei A.; Rezaei N.; Tamizifar B.; Parvaneh L.; Sherkat R.; Ghalehbaghi B.; Kashef S.; Chavoshzadeh Z.; Isaeian A.; Ashrafi F.; Aghamohammadi A.;
J. Clin. Immunol. 30:756-760(2010)
Cited for: VARIANTS LAD1 TYR-128; THR-239 AND ALA-716;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.